Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir.
Darunavir is currently the most recently approved HIV-1 protease inhibitor. It is approved for twice-daily dosing with ritonavir in treatment-experienced patients as young as 6 years of age and is available in numerous pill strengths. Emergence of darunavir-specific mutations is generally slow; therefore it can retain activity against viral strains that are resistant to other protease inhibitors, including tipranavir. Darunavir pharmacokinetics, clinical efficacy, resistance mutations and pharmacodynamics, and adverse effects are reviewed here. Substantial data support its use as a potent, well-tolerated option for salvage therapy in highly treatment-experienced children and adolescents.
Neely
Michael
M
University of Southern California, Keck School of Medicine, Department of Pediatrics, Division of infectious Diseases, Los Angeles, CA, USA.
Kovacs
Andrea
A
Lancet. 2007 Jul 7;370(9581):49-58
17617272
AIDS. 2005 Jun 10;19(9):989-90
15905684
AIDS Res Hum Retroviruses. 2008 Mar;24(3):379-88
18327986
Antimicrob Agents Chemother. 2003 Oct;47(10):3123-9
14506019
AIDS. 2008 Sep 12;22(14):1809-13
18690163
Antimicrob Agents Chemother. 2005 Jun;49(6):2314-21
15917527
Antivir Ther. 2008;13(4):563-9
18672535
J Antimicrob Chemother. 2008 Jan;61(1):183-90
18025025
AIDS. 2007 Feb 19;21(4):395-402
17301557
J Clin Pharmacol. 2008 Jan;48(1):60-5
18094220
J Antimicrob Chemother. 2006 Mar;57(3):579-82
16446377
Top HIV Med. 2008 Dec;16(5):138-45
19106428
Br J Clin Pharmacol. 2008 Aug;66(2):215-21
18460033
J Clin Pharmacol. 2007 Apr;47(4):479-84
17389557
J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):192-5
19131889
Sex Transm Infect. 2003 Oct;79(5):419-21
14573842
Antimicrob Agents Chemother. 2007 Mar;51(3):958-61
17210768
Lancet. 2006 Aug 5;368(9534):476-82
16890834
AIDS. 2008 Jan 2;22(1):165-7
18090413
Antivir Ther. 2007;12(4):509-14
17668559
J Virol. 2007 Dec;81(24):13845-51
17928344
J Antimicrob Chemother. 2007 Oct;60(4):885-8
17646201
AIDS. 2008 Jul 31;22(12):1389-97
18614861
Antimicrob Agents Chemother. 2008 Nov;52(11):3928-32
18725446
Clin Drug Investig. 2008;28(8):479-85
18598093
Antivir Ther. 2008;13(6):839-43
18839785
Ann Pharmacother. 2008 Jul;42(7):1048-59
18577765
Drug Metab Dispos. 2009 Apr;37(4):809-20
19131522
Lancet. 2007 Apr 7;369(9568):1169-78
17416261
Antivir Ther. 2005;10(8):879-92
16430193
Drugs R D. 2007;8(4):241-8
17596110
AIDS Res Ther. 2007 Jul 09;4:15
17620130
Pediatr Infect Dis J. 2008 Aug;27(8):749-52
18664987
J Virol Methods. 2007 Oct;145(1):47-55
17574687
HIV Clin Trials. 2005 Mar-Apr;6(2):73-80
15983891
AIDS. 2008 Sep 12;22(14):1789-98
18753862
Antivir Ther. 2008;13(2):271-9
18505178
Ther Drug Monit. 2007 Dec;29(6):795-801
18043478
Antimicrob Agents Chemother. 2008 Feb;52(2):491-6
18039922
J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):24-31
17621237